Prezzo di chiusura
Altri mercati azionari
|
||
- EGP | - |
Attività
Vendite per attività
EGP in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Medical and Semi-medical Products
100,0
%
| 22 264 | 100,0 % | 33 949 | 100,0 % | +52,48% |
Vendite per regione
EGP in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Egypt
100,0
%
| 22 264 | 100,0 % | 33 949 | 100,0 % | +52,48% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | - | 18/12/00 | |
Chief Executive Officer | - | 18/12/00 | |
Momen Gomaa
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Director/Board Member | - | - | |
Investor Relations Contact | - | 01/11/17 | |
Corporate Officer/Principal | - | - | |
Sales & Marketing | - | - | |
Ahmed Refaat
HRO | Human Resources Officer | - | 01/01/13 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | - | 18/12/00 | |
Chief Executive Officer | - | 18/12/00 | |
Director/Board Member | - | - | |
Director/Board Member | - | - | |
Director/Board Member | - | - | |
Director/Board Member | - | - | |
Chairman | - | - | |
Director/Board Member | - | - | |
Director/Board Member | - | - | |
Director/Board Member | - | - |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 1 008 000 000 | 618 896 741 ( 61,40 %) | 0 | 61,40 % |
Coordinate società
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
-37,88% | 13,99 Mrd | |
-32,35% | 10,67 Mrd | |
-20,52% | 6,75 Mrd | |
+12,54% | 6,29 Mrd | |
-11,51% | 5,88 Mrd | |
+75,00% | 4,96 Mrd | |
-2,48% | 4,61 Mrd | |
-9,20% | 3,74 Mrd | |
-19,40% | 3,16 Mrd |
- Borsa valori
- Azioni
- Azione ISPH
- Azione
- Società Ibnsina Pharma Co